Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mobius Therapeutics was founded in 2006 on the principle of resolution of challenges in the ophthalmic pharmaceutical market. It’s flagship product, Mitosol, was approved by FDA in 2012 and has become the “gold standard” for preparation and delivery of mitomycin-c in the ophthalmic operating room. But it does not end there. Ophthalmic perioperative injectables are a matter of daily frustration. They are often off-labe...
    Mobius Therapeutics was founded in 2006 on the principle of resolution of challenges in the ophthalmic pharmaceutical market. It’s flagship product, Mitosol, was approved by FDA in 2012 and has become the “gold standard” for preparation and delivery of mitomycin-c in the ophthalmic operating room. But it does not end there. Ophthalmic perioperative injectables are a matter of daily frustration. They are often off-label, must be sourced in inconvenient compounded formulations, are presented in enormous, multi-dose vials, and have never been designed for use in the sterile environment of the ophthalmic OR.

    List your booth number for exhibitions, ask us